Catalyst Wire Dossier Catalyst Wire Dossier

Pazopanib Eye Drops (GW786034)

pazopanib
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pazopanib Eye Drops (GW786034), covering 2017-11-13 to 2017-11-13. Get the full timeline:

Most recent: Clinical Trial Update: Study Of The Repeat Dosing Of Ketoconazole On The Pharmacokinetics Of A Single Dose Of Pazopanib (GW786034) Eye Drops [Phase 1]

See pricing